(Q35086051)

6 August 2017

1 reference

title

Parvovirus B19 and autoimmune diseases (English)

1 reference

6 August 2017

Olivier Meyer

1

1 reference

6 August 2017

publication date

1 February 2003

1 reference

6 August 2017

1 reference

6 August 2017

volume

70

1 reference

6 August 2017

issue

1

1 reference

6 August 2017

page(s)

6-11

1 reference

Parvovirus-associated arthritis

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900004-0

7 January 2021

Rheumatic manifestations of parvovirus B19 infection

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900004-0

7 January 2021

Human parvovirus B19 infection. Update

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900004-0

7 January 2021

Clinical manifestations of human parvovirus B19 in adults

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900004-0

7 January 2021

Parvovirus b19 infection associated with acute hepatitis, arthralgias, and rash

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900004-0

7 January 2021

Rheumatologic manifestations of human parvovirus B19 infection in adults. Initial two-year clinical experience

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900004-0

7 January 2021

HUMAN PARVOVIRUS ARTHROPATHY

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900004-0

7 January 2021

HLA and acute arthritis following human parvovirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900004-0

7 January 2021

Autoantibodies following parvovirus B19 infection

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900004-0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900004-0

7 January 2021

Lupus anticoagulant in a patient with parvovirus B19 infection

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900004-0

7 January 2021

Parvovirus B19 and the pathogenesis of rheumatoid arthritis: a case for historical reasoning

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900004-0

7 January 2021

Human parvovirus B19 as a causative agent for rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900004-0

7 January 2021

Induction of an invasive phenotype by human parvovirus B19 in normal human synovial fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900004-0

7 January 2021

Prevalence of antibodies to human parvovirus B19 nonstructural protein in persons with various clinical outcomes following B19 infection

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900004-0

7 January 2021

Persistence of parvovirus B19 in synovial fluid and bone marrow.

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900004-0

7 January 2021

Rheumatoid arthritis after human parvovirus B19 infection

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900004-0

7 January 2021

Parovirus B19-associated mono- and oligoarticular arthritis may evolve into a chronic inflammatory arthropathy fulfilling criteria for rheumatoid arthritis or spondylarthropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900004-0

7 January 2021

The variable clinical picture of arthritis induced by human parvovirus B19. Report of seven adult cases and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900004-0

7 January 2021

Parvovirus B19 and acute joint swelling in rheumatoid arthritis patients

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900004-0

7 January 2021

Low frequency of recent parvovirus infection in a population-based cohort of patients with early inflammatory polyarthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900004-0

7 January 2021

A study of the role of parvovirus B19 in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900004-0

7 January 2021

Presence and significance of human parvovirus B19 DNA in synovial membranes and bone marrow from patients with arthritis of unknown origin

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900004-0

7 January 2021

Detection of multiple viral DNA species in synovial tissue and fluid of patients with early arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900004-0

7 January 2021

Does parvovirus B19 have a role in rheumatoid arthritis?

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900004-0

7 January 2021

Persistence of B19 parvovirus in synovial membranes of patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900004-0

7 January 2021

Ultrastructural features of fetal erythroid precursors infected with parvovirus B19 in vitro: evidence of cell death by apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900004-0

7 January 2021

Parvovirus infection mimicking systemic lupus erythematosus in a pediatric population

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900004-0

7 January 2021

Human parvovirus B19 infection: its relationship with systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900004-0

7 January 2021

Human parvovirus B19 infection resembling systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900004-0

7 January 2021

Parvovirus B19 Infection Can Induce Histiocytic Necrotizing Lymphadenitis (Kikuchi's Disease) Associated with Systemic Lupus Erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900004-0

7 January 2021

Exacerbation of systemic lupus erythematosus during human parvovirus B19 infection

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900004-0

7 January 2021

Acute parvovirus B19 infection in connection with a flare of systemic lupus erythematodes in a female patient

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900004-0

7 January 2021

Human parvovirus B19 infection in patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900004-0

7 January 2021

No serological indications that systemic lupus erythematosus is linked with exposure to human parvovirus B19.

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900004-0

7 January 2021

Adult Still's disease associated with acute human parvovirus B19 infection

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900004-0

7 January 2021

Is Still's disease associated with parvovirus B19 infection?

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900004-0

7 January 2021

Juvenile dermatomyositis in a child infected with human parvovirus B19

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900004-0

7 January 2021

Dermatomyositis associated with the presence of parvovirus B19 DNA in muscle

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900004-0

7 January 2021

A causal role for parvovirus B19 infection in adult dermatomyositis and other autoimmune syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900004-0

7 January 2021

Cytopenia and past human parvovirus B19 infection in patients with primary Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900004-0

7 January 2021

There is no association between polymyalgia rheumatica and acute parvovirus B19 infection

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900004-0

7 January 2021

The role of parvovirus B19 in the pathogenesis of giant cell arteritis: a preliminary evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900004-0

7 January 2021

Systemic vasculitis and atypical infections: report of two cases

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900004-0

7 January 2021

Purpura rhumatoïde de l’adulte et infection à parvovirus B19 : association fortuite ou vascularite induite par le parvovirus B19 ?

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900004-0

7 January 2021

Chronic parvovirus B19 infection and systemic necrotising vasculitis: opportunistic infection or aetiological agent?

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900004-0

7 January 2021

Wegener's granulomatosis and parvovirus B19 infection

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900004-0

7 January 2021

Parvovirus B19 infection, hepatitis C virus infection, and mixed cryoglobulinaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900004-0

7 January 2021

Polyarteritis nodosa and parvovirus B19 infection

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900004-0

7 January 2021

[Periarteritis nodosa and parvovirus B19 infection]

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900004-0

7 January 2021

Active or recent parvovirus B19 infection in children with Kawasaki disease

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900004-0

7 January 2021

Human parvovirus B19 infection in Kawasaki disease

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900004-0

7 January 2021

Polyarteritis nodosa and parvovirus B19

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900004-0

7 January 2021

The presidential candidates and health care

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900004-0

7 January 2021

Autoantibodies and common viral illnesses

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900004-0

7 January 2021

10.1016/S1297-319X(02)00004-0

Identifiers

DOI

1 reference

6 August 2017

1 reference